The Cosmetic Products Notification Portal (CPNP)
Only cosmetic products for which a legal or natural person is designated within the EU as a "Responsible Person" can be placed on the European Union (EU) market. Before placing a cosmetic product on the EU market, the RP must notify it in the Cosmetic Products Notification Portal (CPNP).
Picture of Marta Pinto

Marta Pinto

Regulatory Affairs Associate

CPNP

According to the European Regulation on Cosmetic Products (Regulation (EC) No 1223/2009), before making available a cosmetic product on the market the Responsible Person (RP) shall notify the product in the Cosmetic Products Notification Portal (CPNP).

The CPNP is a free of charge online notification system created for the implementation of the European Cosmetics Regulation. After notification on the CPNP, there is no need for any further notification at national level within the EU.

The use of CPNP is mandatory since 2013. To access the Portal, the user needs a use login, a password, an organization, a role and a profile. The CPNP is relatively easy to use, but there are two user manuals issued by the European Commission, being one specific for cosmetics containing nanomaterials.

The RP or, under certain circumstances, the distributor needs to submit the following information on the CPNP:

  • Name/names (enabling its specific identification) and category of cosmetic product;
  • Name and address of the RP where the PIF is made readily accessible
  • Country of origin (for imported products)
  • Member State in which the cosmetic product is to be placed on the market
  • Contact details of a physical person to contact in case of necessity
  • Presence of nanomaterials, and:
    • their identification, including chemical name (IUPAC) and other descriptors as specified in Regulation:
    • reasonably foreseeable exposure conditions.
  • Name and the CAS or EC number of substances classified as CMR (carcinogenic, mutagenic or toxic to reproduction);
  • Frame formulation (allowing for prompt and appropriate medical treatment in the event of difficulties).

The original labelling, and, where reasonably legible, a photograph of the corresponding packaging must also be notified by the RP.

Part of the information submitted to the CPNP is made electronically available to competent authorities (for market surveillance, market analysis, evaluation and consumer information) and to poison centers or similar bodies established by EU countries (for the purposes of medical treatment).

Competent authorities, EU poison centers, RP and distributors can access the CPNP, but the portal is not accessible to the public.

The notification of cosmetic products containing nanomaterials must be done 6 months prior to placing them on the EU market.

All notifications made in the CPNP remain in the system and it is not possible to dele them. Nevertheless, the RP can create an update version and indicate in the correspondent field that the “product is no longer manufactured”.

Bare in mind that the fact that a cosmetic product has been successfully notified through the CPNP does not necessarily mean that the product fulfills all the requirements of the EU Cosmetic Regulation and is safe.

If you need any information regarding this or other subjects, fell free to contact us at info@criticalcatalyst.com.

References:

  1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products.
  2. Guide to Using CPNP (Cosmetic Products Notification Portal) For Responsible Persons and Distributors. European Commission. 2017

further
reading

cosmetic products

Citral under review: SCCS Preliminary Opinion

The SCCS was tasked by the European Commission to evaluate if the safety levels for Citral, determined through QRA2 based on skin sensitization induction, are sufficient to safeguard consumers. A preliminary opinion was released.

Read More »
cosmetic products

Are sunscreens with Benzophenone-4 safe?

Benzophenone-4 is commonly known as a UV-filter in cosmetic products. Learn what the final opinion of SCCS states about Benzophenone’s safety profile as a UV-filter in cosmetic products.

Read More »
cosmetic products

Is Aluminium in cosmetics safe for human health?

The Scientific Committee on Consumer Safety (SCCS) published its Final Opinion on the safety of Aluminium in cosmetic products. This follows a lengthy review process that began in 2013 when the SCCS was first mandated to evaluate the potential health risks of Aluminium (Al) and its compounds in cosmetics.

Read More »
cosmetic products

Silver in Cosmetics: SCCS preliminary opinion.

Ingredients: SILVER

The recent preliminary opinion from the Scientific Committee on Consumer Safety (SCCS) regarding silver in cosmetics is crucial for consumers and manufacturers. This article breaks down the key points, making it easier to understand the implications and stay informed.

Read More »
news & updates

EU Ecolabel adoption and recognition are on the rise

The Ecolabel certification is a comprehensive program focused on fostering sustainable practices. It evaluates products based on life cycle assessments, where every phase of said life cycle must abide by strict standards to attain the Ecolabel certification. The overarching objective of this certification is minimizing environmental harm from production or consumption activities.

Read More »
cosmetic products

UK proposes ban of wet wipes containing plastic 

The UK has proposed, on April 24, 2024, a regulation titled The Environmental Protection (Wet Wipes Containing Plastic) (England) Regulations 2024, to the World Trade Organization (WTO). The regulation aims to eliminate the supply and sale of plastic-containing wet wipes, including cosmetic ones. The public can offer comments on the draft until June 23, 2024, with adoption expected in September of the same year.

Read More »
news & updates

SCCS preliminary opinion on Citral sensitization endpoint

Ingredients: CITRAL

Date of publication: 27/03/2024

On March 27 2024, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on the safety of Citral in cosmetic products. The deadline for comments is set to June 2, 2024.

Read More »
medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »